|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/06/19 Charles River Labs Int’l, Inc. 10-Q 9/28/19 104:15M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.77M
2: EX-10.1 Material Contract HTML 59K
3: EX-10.2 Material Contract HTML 100K
4: EX-10.3 Material Contract HTML 135K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 38K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 38K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 34K
68: R1 Cover Page HTML 83K
29: R2 Condensed Consolidated Statements of Income HTML 133K
(Unaudited)
42: R3 Condensed Consolidated Statements of Comprehensive HTML 63K
Income (Unaudited)
99: R4 Condensed Consolidated Balance Sheets (Unaudited) HTML 148K
67: R5 Condensed Consolidated Balance Sheets (Unaudited) HTML 52K
(Parenthetical)
28: R6 Condensed Consolidated Statements of Cash Flows HTML 130K
(Unaudited)
41: R7 Condensed Consolidated Statements of Changes in HTML 101K
Equity (Unaudited)
102: R8 Basis of Presentation HTML 50K
64: R9 Business Acquisitions HTML 143K
23: R10 Revenue From Contracts With Customers HTML 142K
55: R11 Segment Information HTML 208K
88: R12 Supplemental Balance Sheet Information HTML 101K
76: R13 Venture Capital and Other Investments HTML 44K
24: R14 Fair Value HTML 120K
56: R15 Goodwill and Intangible Assets HTML 95K
89: R16 Long-Term Debt and Finance Lease Obligations HTML 98K
77: R17 Equity and Noncontrolling Interests HTML 131K
22: R18 Income Taxes HTML 41K
57: R19 Pension and Other Post-Retirement Benefit Plans HTML 59K
93: R20 Stock-Based Compensation HTML 57K
59: R21 Foreign Currency Contracts HTML 89K
25: R22 Restructuring and Asset Impairments HTML 151K
37: R23 Leases HTML 281K
94: R24 Commitments and Contingencies HTML 33K
60: R25 Basis of Presentation (Policies) HTML 58K
26: R26 Business Acquisitions (Tables) HTML 115K
38: R27 Revenue From Contracts With Customers (Tables) HTML 165K
95: R28 Segment Information (Tables) HTML 267K
58: R29 Supplemental Balance Sheet Information (Tables) HTML 112K
79: R30 Fair Value (Tables) HTML 106K
92: R31 Goodwill and Intangible Assets (Tables) HTML 97K
54: R32 Long-Term Debt and Finance Lease Obligations HTML 53K
(Tables)
21: R33 Equity and Noncontrolling Interests (Tables) HTML 111K
78: R34 Pension and Other Post-Retirement Benefit Plans HTML 58K
(Tables)
91: R35 Stock-Based Compensation (Tables) HTML 55K
53: R36 Foreign Currency Contracts (Tables) HTML 84K
20: R37 Restructuring and Asset Impairments (Tables) HTML 148K
80: R38 Leases (Tables) HTML 190K
90: R39 BUSINESS ACQUISITIONS - Narrative (Details) HTML 114K
62: R40 BUSINESS ACQUISITIONS - Purchase Price Allocation HTML 98K
(Details)
98: R41 BUSINESS ACQUISITIONS - Definite-Lived Intangible HTML 50K
Assets (Details)
45: R42 BUSINESS ACQUISITIONS - Pro Forma Information HTML 39K
(Details)
35: R43 REVENUE FROM CONTRACTS WITH CUSTOMERS - HTML 50K
Disaggregation of Revenues by Major Business Line
(Details)
61: R44 REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule HTML 60K
of Estimated Revenue Related to Performance
Obligations (Details)
97: R45 REVENUE FROM CONTRACTS WITH CUSTOMERS - Narrative HTML 39K
(Details)
44: R46 REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule HTML 38K
of Client Receivables, Contract Assets and
Contract Liabilities (Details)
34: R47 SEGMENT INFORMATION - Narrative (Details) HTML 31K
63: R48 SEGMENT INFORMATION - Revenue and Other Financial HTML 51K
Information by Reportable Segment (Details)
96: R49 SEGMENT INFORMATION - Reconciliation of Segment HTML 43K
Operating Income, Depreciation and Amortization,
and Capital Expenditures (Details)
81: R50 SEGMENT INFORMATION - Revenue Per Significant HTML 40K
Product or Service (Details)
70: R51 SEGMENT INFORMATION - Summary of Unallocated HTML 51K
Corporate Overhead (Details)
18: R52 SEGMENT INFORMATION - Disaggregation of Revenue by HTML 45K
Geographic Area (Details)
51: R53 Supplemental Balance Sheet Information (Details) HTML 127K
82: R54 VENTURE CAPITAL AND OTHER INVESTMENTS - Narrative HTML 52K
(Details)
71: R55 FAIR VALUE - Narrative (Details) HTML 40K
19: R56 FAIR VALUE - Fair Value of Assets and Liabilities HTML 67K
(Details)
52: R57 FAIR VALUE - Contingent Consideration (Details) HTML 42K
83: R58 GOODWILL AND INTANGIBLE ASSETS - Rollforward of HTML 45K
Goodwill (Details)
69: R59 GOODWILL AND INTANGIBLE ASSETS - Schedule of Other HTML 54K
Intangible Assets (Details)
31: R60 LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - HTML 67K
Schedule of Long-Term Debt (Details)
39: R61 LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - HTML 142K
Narrative (Details)
103: R62 EQUITY AND NONCONTROLLING INTERESTS - Earnings Per HTML 60K
Share (Details)
65: R63 EQUITY AND NONCONTROLLING INTERESTS - Narrative HTML 73K
(Details)
32: R64 EQUITY AND NONCONTROLLING INTERESTS - Treasury HTML 44K
Shares (Details)
40: R65 EQUITY AND NONCONTROLLING INTERESTS - Accumulated HTML 58K
Other Comprehensive Income (Loss) (Details)
104: R66 EQUITY AND NONCONTROLLING INTERESTS - Rollforward HTML 64K
of Redeemable Noncontrolling Interest (Details)
66: R67 Income Taxes (Details) HTML 49K
30: R68 Pension and Other Post-Retirement Benefit Plans HTML 53K
(Details)
43: R69 STOCK-BASED COMPENSATION - Stock Based HTML 43K
Compensation Expense (Details)
50: R70 STOCK-BASED COMPENSATION - Summary of Stock-Based HTML 47K
Compensation Grants (Details)
16: R71 FOREIGN CURRENCY CONTRACTS - Narrative (Details) HTML 35K
75: R72 FOREIGN CURRENCY CONTRACTS - Schedule of Notional HTML 48K
and Fair Value of Foreign Currency Contracts
(Details)
87: R73 FOREIGN CURRENCY CONTRACTS - Schedule of HTML 45K
Derivative Instruments on Statements of Income
(Details)
47: R74 RESTRUCTURING AND ASSET IMPAIRMENTS - HTML 49K
Restructuring Costs by Classification on the
Statements of Income (Details)
13: R75 RESTRUCTURING AND ASSET IMPAIRMENTS - HTML 44K
Restructuring Costs by Reportable Segment
(Details)
72: R76 RESTRUCTURING AND ASSET IMPAIRMENTS - HTML 68K
Restructuring Costs by Related to RMS
Restructuring Initiative (Details)
84: R77 RESTRUCTURING AND ASSET IMPAIRMENTS - Narrative HTML 55K
(Details)
46: R78 RESTRUCTURING AND ASSET IMPAIRMENTS - Rollforward HTML 42K
of Severance and Transition Costs Liability
(Details)
17: R79 LEASES - Schedule of Cumulative Effect of Adoption HTML 54K
of ASC 842 (Details)
49: R80 LEASES - Narrative (Details) HTML 52K
15: R81 LEASES - Right-of-Use Lease Assets and Lease HTML 47K
Liabilities in Condensed Consolidated Financial
Statements (Details)
74: R82 LEASES - Components of Operating and Finance Lease HTML 47K
Costs (Details)
86: R83 LEASES - Supplemental Cash Flow Information HTML 44K
(Details)
48: R84 LEASES - Weighted Average Remaining Lease Term and HTML 41K
Discount Rates (Details)
14: R85 LEASES - Schedule of Future Minimum Lease Payments HTML 70K
Under Non-Cancellable Leases After Adoption
(Details)
73: R86 LEASES - Schedule of Future Minimum Lease HTML 71K
Payments, Non-Cancellable Operating Leases Before
Adoption (Details)
100: R9999 Uncategorized Items - crl928201910-q.htm HTML 34K
33: XML IDEA XML File -- Filing Summary XML 191K
27: XML XBRL Instance -- crl928201910-q_htm XML 4.21M
101: EXCEL IDEA Workbook of Financial Reports XLSX 118K
9: EX-101.CAL XBRL Calculations -- crl-20190928_cal XML 364K
10: EX-101.DEF XBRL Definitions -- crl-20190928_def XML 893K
11: EX-101.LAB XBRL Labels -- crl-20190928_lab XML 2.11M
12: EX-101.PRE XBRL Presentations -- crl-20190928_pre XML 1.31M
8: EX-101.SCH XBRL Schema -- crl-20190928 XSD 199K
85: JSON XBRL Instance as JSON Data -- MetaLinks 473± 709K
36: ZIP XBRL Zipped Folder -- 0001100682-19-000030-xbrl Zip 416K
| Exhibit |
1. | I
have reviewed this quarterly report on Form 10-Q for the quarter ended September 28, 2019 of the registrant; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have: |
a. | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and |
d. | disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The
registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
a. | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and |
b. | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
/s/ James
C. Foster | |||
Chairman, President and Chief Executive Officer Charles River Laboratories International, Inc. | |||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/6/19 | 8-K | ||
| For Period end: | 9/28/19 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/17/21 Charles River Labs Int’l, Inc. 10-K 12/26/20 138:18M |